AstraZeneca CEO: China at heart of global biotech innovation, 100b yuan investment by company to deepen global cooperation
chinadaily.com.cn |
Updated: 2026-02-05 13:53
Share
Share - WeChat
Pascal Soriot, CEO of AstraZeneca, told China Daily that the company has been deeply rooted in China for decades, and that China has emerged as a cornerstone of global innovation in life sciences and medicine over the past five to six years.
